Pelvic Organ Prolapse: Evaluation and Treatment Options

Clinical Practice Update — Symptom Assessment, POP-Q Staging, and Choosing Between Conservative and Surgical Care

This is an original clinical education article informed by current guidelines and evidence. See References below for source documents.

MDA-POP-2026 · 13 min read
Clinical Focus
Evaluation and pelvic organ prolapse treatment in adult women
Target Audience
Gynecologists, primary care physicians, urogynecology referrers, residents, nurse practitioners
Setting
Outpatient gynecology, primary care, urogynecology referral
Source Evidence
  • •ACOG/AUGS Practice Bulletin on Pelvic Organ Prolapse (2024)
  • •NICE Guideline NG123 — Urinary Incontinence and Pelvic Organ Prolapse (2019, updated 2024)
  • •Cochrane Review — Surgery for Women with Apical Vaginal Prolapse (2023)
  • •POPPY Trial — Pelvic Floor Muscle Training for Prolapse (Lancet, 2014)

Key Clinical Takeaways

Effective pelvic organ prolapse treatment begins with one principle: treat the symptoms, not the anatomy. Many women with descent on examination feel nothing and need only reassurance. The points below distill current evidence into actionable rules for evaluation and management.

Clinical evaluation and pelvic organ prolapse treatment pathway showing POP-Q staging, pessary options, and surgical repair choices
Overview of the clinical approach to pelvic organ prolapse treatment in women.
  1. 1Stage every prolapse with POP-Q staging, but base management on bother, not on the stage number alone → Evaluation
  2. 2Offer watchful waiting to any woman with mild or asymptomatic descent → Conservative Care
  3. 3Recommend supervised pelvic floor muscle training first-line for stage 1–2 symptomatic prolapse → Conservative Care
  4. 4Offer a vaginal pessary as an effective alternative to surgery at any prolapse stage → Pessary Management
  5. 5Prescribe vaginal estrogen alongside a pessary in postmenopausal women to reduce erosion → Pessary Management
  6. 6Match the surgical approach to the compartment that has prolapsed, not to a single default operation → Surgical Options
  7. 7Counsel patients that transvaginal mesh is no longer used for routine primary repair → Surgical Options
  8. 8Discuss colpocleisis as a durable, low-morbidity option for older women not seeking to preserve coital function → Surgical Options
  9. 9Investigate occult stress incontinence before prolapse surgery, since repair can unmask it → Pre-Operative Workup

Evaluating a Woman Before Pelvic Organ Prolapse Treatment

A structured evaluation does two things: it confirms which compartments have descended and it establishes how much the descent bothers the woman. Both pieces drive every subsequent pelvic organ prolapse treatment decision, because a stage 3 cystocele in an asymptomatic woman and a stage 1 prolapse in a distressed one call for opposite approaches.

1

Document symptom burden with a validated symptom questionnaire before deciding on any intervention. The degree of bother, not the anatomical stage, determines whether treatment is warranted.

Strong Rec Moderate Evidence ACOG/AUGS 2024
2

Perform a POP-Q examination to record the leading edge of each compartment relative to the hymen. Reproducible staging allows consistent communication and meaningful follow-up over time.

Strong Rec High Evidence ACOG/AUGS 2024
3

Examine the woman in a position that reproduces her maximal descent, standing if needed, since supine examination frequently understates the prolapse she experiences during daily activity.

Moderate Rec Low Evidence NICE NG123
4

Evaluate for coexisting bladder and bowel dysfunction, including urinary urgency, incomplete emptying, and obstructed defecation, which influence both the choice and the sequencing of treatment.

Strong Rec Moderate Evidence ACOG/AUGS 2024
Clinical Pearl: A woman who reports a vaginal bulge she can see or feel has the single most predictive symptom of prolapse. If that symptom is absent, descent on examination rarely needs treatment.
When Imaging or Urodynamics Add Value

Routine imaging is not required to diagnose prolapse, which remains a clinical diagnosis. Reserve dynamic MRI or translabial ultrasound for complex multicompartment cases, suspected enterocele, or planning a redo repair. Consider urodynamic assessment when stress incontinence symptoms coexist or when prolapse reduction unmasks leakage.

Investigations should answer a specific question that will change management, not simply complete a checklist.

Conservative Pelvic Organ Prolapse Treatment

For most women with early-stage symptomatic descent, conservative pelvic organ prolapse treatment is the appropriate first step. It carries minimal risk, can be started immediately, and does not foreclose surgery later. The two pillars are pelvic floor muscle training and lifestyle modification.

5

Refer for supervised pelvic floor muscle training as first-line therapy in women with stage 1 or stage 2 symptomatic prolapse. A structured programme of at least 16 weeks improves symptoms and prolapse severity more than lifestyle advice alone.

Strong Rec High Evidence POPPY Trial 2014 NICE NG123
6

Counsel patients on weight reduction, management of chronic cough, and avoidance of repeated heavy lifting. Reducing intra-abdominal pressure addresses a modifiable driver of progression.

Moderate Rec Low Evidence ACOG/AUGS 2024
7

Treat associated constipation actively with fibre, fluids, and stool softeners. Straining at defecation worsens both prolapse symptoms and the chance of post-operative recurrence.

Moderate Rec Low Evidence NICE NG123
Practice Note: Set expectations early. Pelvic floor training reduces symptom bother but rarely reverses anatomical descent. Framing the goal as “feeling better” rather than “putting it back” prevents disappointment and dropout.

Vaginal Pessaries: A Non-Surgical Mainstay

A vaginal pessary is an effective option for women at any prolapse stage who wish to avoid or delay surgery, who are awaiting an operation, or who are unfit for one. Roughly two-thirds of women fitted with a pessary continue using it successfully at one year, making it a genuine long-term alternative rather than a stopgap.

8

Offer a pessary trial to every woman considering surgery, since many achieve durable symptom control without an operation. Start with a ring pessary for most anterior and apical prolapse and reserve space-filling types such as the Gellhorn for advanced descent.

Strong Rec Moderate Evidence ACOG/AUGS 2024
9

Prescribe topical vaginal estrogen in postmenopausal pessary users unless contraindicated. Local estrogen improves tissue integrity and reduces the risk of erosion, bleeding, and discharge.

Moderate Rec Moderate Evidence ACOG/AUGS 2024
10

Arrange a follow-up review within a few weeks of the initial fitting, then at regular intervals, to check comfort, retention, and the vaginal mucosa. Teach self-management of removal and reinsertion where the woman is able and willing.

Moderate Rec Low Evidence NICE NG123
Warning
A neglected pessary left in place for months or years can erode into the bladder or rectum and, rarely, lead to fistula. Every woman fitted with a pessary needs a reliable follow-up plan and clear instructions to report bleeding, pain, or discharge.

Surgical Options by Compartment

Surgery is offered when symptoms persist despite conservative measures, when a pessary is unsuitable or declined, or when the woman prefers a definitive repair. The operation is chosen to match the affected compartment and the woman’s goals, including whether she wishes to preserve the uterus and coital function.

11

Perform an apical suspension procedure whenever the apex has descended, since unaddressed apical support is a leading cause of recurrence after isolated anterior or posterior repair. Sacrocolpopexy and sacrospinous fixation are both well-supported, with the choice guided by route, age, and surgical expertise.

Strong Rec High Evidence Cochrane 2023
12

Repair anterior and posterior compartment defects with native-tissue colporrhaphy as the standard primary approach. Native-tissue repair avoids the complications that led to the withdrawal of transvaginal mesh for routine use.

Strong Rec Moderate Evidence NICE NG123
13

Do not use transvaginal synthetic mesh for primary prolapse repair outside specialist research settings. Regulatory bodies have restricted its use after reports of mesh exposure, chronic pain, and dyspareunia.

Against Moderate Evidence NICE NG123 FDA 2019
14

Consider colpocleisis for older women with advanced prolapse who do not wish to retain the option of penetrative intercourse. This obliterative procedure offers high anatomical success with short operating time and low complication rates.

Conditional Rec Moderate Evidence ACOG/AUGS 2024
15

Discuss uterine preservation as an option in women who wish to keep their uterus and have no other indication for hysterectomy. Hysteropexy achieves comparable short-term outcomes to hysterectomy-based repair in suitable candidates.

Moderate Rec Moderate Evidence Cochrane 2023

Surgical Approaches: Matching Procedure to Patient

ProcedureCompartment AddressedBest Suited ForCounselling Points
Anterior colporrhaphyAnterior (cystocele)Symptomatic bladder bulge with good apical supportRecurrence rises if apical descent is left unrepaired
Posterior colporrhaphyPosterior (rectocele)Symptomatic rectocele, obstructed defecationAvoid over-narrowing to prevent dyspareunia
Sacrospinous fixationApical (vaginal route)Apical prolapse, woman preferring vaginal surgeryFaster recovery; small risk of buttock pain
SacrocolpopexyApical (abdominal route)Vault prolapse, younger active women, redo repairDurable but longer recovery; uses abdominal mesh graft
ColpocleisisAll compartments (obliterative)Frail, older women not seeking coital functionIrreversible loss of penetrative intercourse; counsel clearly

Pre-Operative Workup and Counselling

Thorough preparation reduces surprises after surgery. The two issues most often overlooked are occult stress incontinence and unrealistic expectations about what repair can deliver.

16

Evaluate for occult stress urinary incontinence with prolapse reduction before surgery. Repairing the prolapse can unmask leakage that was previously hidden by kinking of the urethra.

Moderate Rec Moderate Evidence ACOG/AUGS 2024
17

Counsel patients on realistic recurrence rates and the possibility of needing a further procedure. Shared decision-making about acceptable trade-offs improves satisfaction regardless of the operation chosen.

Strong Rec Moderate Evidence NICE NG123
18

Refer complex, recurrent, or mesh-complication cases to a specialist multidisciplinary urogynecology service. Concentrating difficult cases in experienced centres improves outcomes and access to the full range of options.

Strong Rec Low Evidence NICE NG123
Clinical Pearl: Whether to add a concurrent anti-incontinence procedure to prolapse surgery is a genuine judgement call. A staged approach spares some women an operation they never needed, while a combined approach spares others a second anaesthetic. Make the choice with the patient.

Clinical Decision Pathway

A practical, question-based approach to selecting a management strategy. Follow the questions in order.

Choosing a Management Strategy: 4 Questions
Question 1: Is the prolapse causing bother?
No bothersome symptoms → reassure, offer watchful waiting, review if symptoms develop.
Bothersome bulge or pressure → proceed to Question 2.
Question 2: Has conservative care been tried?
Not yet → offer supervised pelvic floor muscle training and lifestyle modification first.
Tried and insufficient → proceed to Question 3.
Question 3: Does the woman want to avoid or defer surgery?
Yes, or unfit for surgery → fit a vaginal pessary, add vaginal estrogen if postmenopausal.
Prefers definitive repair → proceed to Question 4.
Question 4: Which compartment is affected, and what are her goals?
Apical descent present → include apical support (sacrocolpopexy or sacrospinous fixation).
Isolated anterior or posterior defect → native-tissue colporrhaphy.
Older woman, no coital function desired → discuss colpocleisis.

Monitoring and Follow-Up

Management ChoiceWhen to ReviewWhat to AssessCommon Pitfalls
Watchful waitingWhen symptoms changeNew or worsening bulge, bladder or bowel symptomsDischarging without a clear route back into care
Pelvic floor trainingDuring and at end of programmeSymptom bother, technique, adherenceExpecting anatomical reversal rather than symptom relief
Vaginal pessaryFew weeks after fitting, then regularlyComfort, retention, vaginal mucosa for erosionLosing the patient to follow-up and risking erosion
After surgeryEarly post-op, then medium-termWound healing, recurrence, new incontinence, sexual functionAttributing all new symptoms to the prolapse rather than the repair

Evidence in Context

What the evidence shows, where the major frameworks agree, and where genuine uncertainty remains.

Where ACOG/AUGS and NICE Agree

Both frameworks agree that management should be driven by symptom bother rather than anatomical stage, that conservative options should be offered before surgery, and that apical support must be addressed when the apex has descended. Both also endorse the retreat from transvaginal mesh for routine primary repair.

Pelvic Floor Training: What the Trials Show

The POPPY trial demonstrated that a supervised, individualised programme of pelvic floor muscle training reduced prolapse symptoms compared with a simple lifestyle leaflet. The effect is most reliable in earlier-stage prolapse, and benefit depends heavily on supervision and adherence rather than on home exercises alone.

Apical Repair: Abdominal Versus Vaginal Route

The Cochrane review of apical prolapse surgery found that abdominal sacrocolpopexy tends to offer lower recurrence than vaginal procedures, at the cost of longer recovery and operating time. Sacrospinous fixation remains a sound vaginal alternative, and the best choice depends on the woman’s age, activity level, and surgical priorities.

The Mesh Story and Where It Leaves Us

Reports of mesh exposure, chronic pelvic pain, and dyspareunia led multiple regulators to restrict or withdraw transvaginal mesh kits for prolapse. Abdominally placed mesh in sacrocolpopexy is a distinct procedure with a different safety profile and remains an accepted option. The lesson has reshaped how new devices are introduced and how thoroughly women are now counselled.

References

  1. 1.Hagen S, Stark D, Glazener C, et al. Individualised pelvic floor muscle training in women with pelvic organ prolapse (POPPY): a multicentre randomised controlled trial. Lancet. 2014;383(9919):796–806. doi:10.1016/S0140-6736(13)61977-7
  2. 2.Maher C, Feiner B, Baessler K, et al. Surgery for women with apical vaginal prolapse. Cochrane Database Syst Rev. 2023;7:CD012376. doi:10.1002/14651858.CD012376.pub2
  3. 3.American College of Obstetricians and Gynecologists and American Urogynecologic Society. Pelvic Organ Prolapse. Obstet Gynecol. 2024;143(1):e1–e30. pubmed.ncbi.nlm.nih.gov/37486661
  4. 4.National Institute for Health and Care Excellence. Urinary incontinence and pelvic organ prolapse in women: management. NICE Guideline [NG123]. 2019. nice.org.uk/guidance/ng123

How to Read the Evidence Tags

Every recommendation carries two tags for recommendation strength and evidence quality — Medaptly’s own simplified interpretations, plus a source tag.

Recommendation Strength

TagWhat It Means
Strong RecHigh-quality evidence broadly supports this action.
Moderate RecThe weight of evidence favours this action.
Conditional RecThe benefit is less certain — individualise.
AgainstEvidence shows no benefit or potential harm.

Evidence Quality

TagWhat It Means
High EvidenceMultiple well-designed RCTs or high-quality meta-analyses.
Moderate EvidenceSingle RCT or large observational studies.
Low EvidenceExpert consensus or small studies.

Article Information

For Educational Purposes Only. This is original clinical education content informed by current published guidelines and clinical evidence. It does not constitute medical advice, is not endorsed by any guideline body, and does not replace individualised clinical judgement or local formulary guidance. Treatment decisions and drug dosages should always be verified before prescribing. Readers are encouraged to consult the original source guidelines listed in References.
The Medaptly Digest

Stay current in your specialty.

The evidence that moved practice this week — guideline shifts, landmark trials, and cases worth a second look — in a few high-yield minutes.

Free · One issue a week · Unsubscribe anytime

Which specialties?

Pick the ones you want — choose as many as you like.

Your newsletters

RELATED CONTENT

Explore More in This Specialty

Handpicked content from across articles, cases, research, guidelines, news, and presentations.

Loading related content...